Smartphone Technology to Alleviate Malignant Pain (STAMP)
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 70
Summary
- Conditions
- Cancer
- Opioid Use
- Pain Management
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: Non-RandomizedIntervention Model: Sequential AssignmentIntervention Model Description: This study is being conducted through 5 sequential activities. Activities 3, 4, and 5 all involve human subject participants. Activity 3 (user acceptability testing) participants will be reported under arm/group 1. Activity 4 (pilot testing) participants will be reported under arm/group 2.Masking: None (Open Label)Primary Purpose: Health Services Research
Participation Requirements
- Age
- Between 21 years and 125 years
- Gender
- Both males and females
Description
The purpose of the study is to develop the STAMP app (Smartphone Technology to Alleviate Malignant Pain). This app will be used by patients with advanced cancer to track symptoms and receive tailored symptom management advice. This project will involve 5 specific activities: Activity 1 - Content Dev...
The purpose of the study is to develop the STAMP app (Smartphone Technology to Alleviate Malignant Pain). This app will be used by patients with advanced cancer to track symptoms and receive tailored symptom management advice. This project will involve 5 specific activities: Activity 1 - Content Development (working groups) Activity 2 - Programming and testing of app algorithms Activity 3 - User acceptability testing Activity 4 - Pilot testing Activity 5 - Patient Qualitative Interviews Activities 1 and 2 will involve the development of the content and functionalities for the STAMP app. Activity 3 (the user acceptability testing phase of the project) will be conducted to identify and address any problems with the developed tool. User acceptability testing will involve interviews and focus groups with patients and providers who have been shown the app. The information gathered from these interviews and groups will be used to improve the application before it undergoes pilot testing. Activity 4 (pilot testing) will be conducted to demonstrate the utilization and efficacy of the STAMP app among patients with chronic cancer pain and their cancer care providers. Activity 5 (patient qualitative interviews) will be conducted with patients to learn more about their experiences with a cancer diagnosis and chronic pain management.
Tracking Information
- NCT #
- NCT03717402
- Collaborators
- National Institute of Nursing Research (NINR)
- Investigators
- Principal Investigator: Andrea Enzinger, MD Dana-Farber Cancer Institute
Get Well Soon